This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Hapvida-Plamed deal assigned to CADE Councilor Braido in Brazil

( September 17, 2020, 13:27 GMT | Official Statement) -- MLex Summary: Hapvida Assistência Médica's purchase of the customer portfolio, equipment and medical care unit from rival health insurer Plamed Plano de Assistência Médica has been assigned to Brazilian competition authority Councilor Conselheiro Luis Henrique Bertolino Braido after the agency's Superintendence said in an opinion that the deal shouldn't be approved, because even if conditioned on structural remedies, it would harm consumers. After Braido's analysis, the case will be referred to the authority's governing Tribunal for a definitive ruling.See CADE statement below (in Portuguese)....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login